Trial intelligence / Profile preview

Dexmedetomidine-midazolam vs Ketamine-midazolam for Emergence Delirium in Pediatric Cardiac Catheterization

NCT07427446Phase 4Recruiting

Sponsor
Kasr Al Ainy Hospital
Start
Feb 2026
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine, ketamine in emergence delirium (ED), sponsored by Kasr Al Ainy Hospital. Started Feb 2026; status: recruiting.

02

Drugs

dexmedetomidineketamine
03

Conditions

emergence delirium (ED)

Beyond the preview

Go deeper on NCT07427446.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07427446.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call